Professor Coombs replied that in those particular cases the damage was not purely antibody-dependent; it required complement and some of the components might not flow quite so well as antibody.
An unidentified speaker said that in his experience there were also immune complexes, at least in inflammatory arthritis, such as rheumatoid arthritis. Immune complexes diffused into the cartilage, and might be in the neighbourhood of the matrix. It was possible that endocytosis of immune complexes could occur into a chondrocyte cell which might have lysosomal enzymes in it, releasing them simply by the endocytosis mechanism.
Professor Coombs thought that this sort of Type II stimulatory activity was one which should be borne in mind because one did not normally associate the lesions produced with an allergic type of reaction. Therefore, one might come across them in circumstances where an allergic event had not been suspected. Dr G Holm (Stockholm) asked Professor Coombs to comment further on the difference between Type II, when it involved lymphoid cells, and Type IV. There were Type IV reactions which apparently did not involve T-cells, but which might involve B-cells. Were these called Type II reactions, or did they remain Type IV reactions?
Professor Coombs thought that if an allergized lymphoid cell was involved it would be Type IV. If, however, the lymphocyte was a nonallergized cofactor, as it were, like complement then it became Type II reaction.
Asked if he restricted Type IV to T-cells or to Bcells, Professor Coombs said that it depended on the dogma. He would say that it was an allergized lymphoid cell, presumably T, but his mind was not completely closed.
Dr M Feiwel (London) wondered whether, as the Gell and Coombs classification was firmly established in undergraduate teaching, there was not a case for splitting Type Ill into two types. In the first the lesions resulted from antigen reacting with antibody across vessel walls. In the second the lesions were produced by circulating soluble immune complexes which were deposited at a distance from the site of interaction of antigen and antibody.
Professor Coombs said that that was a difficult question. There was nothing unique about this classification, except that it was simple, which was its appeal, and, on the whole, it held. If one began to subdivide the classification, the process would be more complicated and people would begin to worry. However, he was certainly ready to listen to suggestions.
One criticism which had always been made was with regard to numbering them I, II, IIf and IV, rather than giving them a name. The trouble in immunology was that a name was often used in respect of a number of different reactions, for instance anaphylaxis, which certainly covered types I, II and III, and this could lead to difficulty. Immune Deficiences in Childhood The gross but rather rare deficiencies of immune reactions in infancy are fairly well understood, and most of us are familiar with various hypogammaglobulinwmic and lymphopenic immune deficiency states, some of which are rapidly fatal (Table 1) . My paper considers the less gross forms of immune deficiency, which present more longterm problems, since they can carry on to adult life or may arise for the first time as a complication of an acquired disease. Ataxia telangiectasia (Peterson et al. 1966 ) is not a common condition. It involves a malformation of blood vessels which leads to ischemic defects of the brain, thymus and other organs. The presenting features include cerebellar ataxia and dementia, and telangiectases are widespread. It is not at first associated with an obvious immunological deficiency although there is a low IgA level in 720 of cases and a low IgG level in 30% (Peterson & Good 1968 ). There is, however, an insidiously developing immune deficiencyone that is compatible with prolonged survival. The complications that follow include recurrent infections of the sinuses and lungs (South 1968) and also a high incidence of malignant disease, which Good et al. (1971) estimate at between 10% and 15 Y (Table 2 ). This high incidence of cancer Table 2 Immunodeficiency and malignant disease (After Good et al. 1971 1-10 appears to be a feature of all immune deficiency states, certainly of those which are compatible with prolonged survival. The Wiskott-Aldrich syndrome is another condition which is characterized by slowly developing, long-term changes, starting with eczema, diarrhoea and infections, and including neoplastic disease. Eighteen boys with this sex-limited condition have been studied by Cooper et al. (1968) who found, over the years, abnormal platelets, a progressive lymphocytopenia, and a cellular depletion of the paracortical areas of lymph nodes. The humoral antibody response was normal, except to certain polysaccharide-containing antigens such as the blood group antigens. The response to virus infections, including vaccination, was normal in early life but became abnormal later on.
Immune Deficiency in Adult Life
This is part of the background against which the more insidious immune deficiencies of adult life can be assessed. These do not always produce symptoms. Undetectable IgA levels have been reported in healthy individuals in between 0.14 Y/-0.42% of cases in different series and this may be compensated by high levels of IgG and IgM in the blood and in the secretions (Hanson 1968 , Savilhahti 1973 ). Nevertheless, Heremans & Crabbe (1968) noted that an isolated IgA deficiency may be associated with infections, especially of the sinuses and lungs, and also with allergy to food and drugs (West et al. 1962) , with autoimmune disorders such as systemic lupus, or with a sprue-like syndrome, especially in adults.
The association of allergic and autoimmune phenomena with various types of immunological defect is a close one. A high incidence of autoantibodies has been reported in agammaglobulinmmic subjects and in their first-degree relatives, suggesting the possibility that this phenomenon may represent not a hyperimmune response but a secondary manifestation of immune deficiency (Fudenberg 1968 ). Cases have been described with an early onset of pernicious anemia (Twomey et al. 1969) or with rheumatoid arthritis, dermatomyositis, hemolytic anmmia and other so-called autoimmune diseases (Blaker & Fisher 1967 , Wollheim 1968 ). Conversely Kaufman & Hobbs (1970) noted that 7 % of subjects who were thought to have allergic symptoms had levels of IgA, IgG or IgM which were more than two standard deviations below the normal range.
There is another condition which is seen in longstanding immune deficiency. At least 9 cases of amyloidosis have been reported in agammaglobulinemic patients (Teilum 1968 ), suggesting that amyloid can develop without the gamma globulin level being above about 10% of normal.
Here it is suggested that changes occur in the reticuloendothelial cells which, after protracted stimulation of the immune mechanism, fail to produce globulins normally. These cells undergo changes which may be demonstrated by PAS staining, and finally they lay down amyloid.
In summary, the late clinical features which may arise among surviving patients with immune deficiency states include not only infections but diarrhoea and a sprue-like syndrome, pernicious anamia and haemolytic anamia, food and drug allergies, systemic lupus and dermatomyositis, various forms of cancer, and amyloid. It is interesting that some of these conditions are still widely regarded, not as an abnormal immune response, but as a kind of immunological excess which it is the fashion to treat by whatever immunosuppressive drugs are available. The correctness of this view needs to be reassessed.
LATE-DEVELOPING IMMUNE DEFICIENCES
In the rest of this paper I propose to discuss some of the so-called secondary immune deficiencies, especially those which are seen in association with infections, with renal failure and with cancer. In many cases it is clear that the immune deficiency is not entirely secondary, and for convenience such conditions as chronic candidiasis may be included here, though many of these patients have a well-studied genetic defect.
Immune Deficiencies in Infection
Von Pirquet (1908) may have been the first to note that a transient suppression of an immune response sometimes occurs during the course of an infection such as measles. He noted that the ability to produce a skin reaction to tuberculin disappeared during the first days of the measles rash and reappeared after a week. Starr & Berkovich (1964) have analysed the situation further by studying 20 tuberculous children. Seven of these were admitted with measles and found to have tuberculosis, while the others were under treatment for tuberculosis when they developed measles. Skin tests with three different strengths of tuberculin were carried out at various times and the study was concerned with the weakest strength which produced a reaction. For comparison 24 children who received measles vaccine were also tested. In this way, the depressed skin reaction at the onset of measles was clearly shown and some of the observations of von Pirquet were substantiated (Fig 1) .
Although the mechanism of these changes has not been studied, White & Boyd (1973) have shown that in children dying of measles or at some time afterwards from some other cause, there were severe destructive changes in the thymus. It is known that these changes may per- (datafrom Starr & Berkovich 1964) sist for at least two months and that they also occur with other infections. Infectious mononucleosis is another infectivc condition in which the skin reaction to tuberculin can be transiently depressed. This is a condition with a well-known association with EB virus antibodies, but Sutton et al. (1973) have shown that complement-fixing antibodies are less evident during and immediately after the infection than in the population at large (Table 3) . Leprosy provides yet another example. Skin hypersensitivity reactions are frequently depressed in the lepromatous form of the disease but are more normal in cases in which the infection has been treated and the disease arrested (Waldorf et al. 1966 , Bullock 1968 ). In leprosy, however, the picture is by no means simple. Some patients, in the tuberculoid form of the disease, muster a vigorous cellular response, and this has been said to be associated with a relatively good prognosis even without therapy (Sheagren et al. 1959) .
Whatever the initial reason for an impaired immune reaction in infection, there are many instances, as in candidiasis, where the ability to respond seems to recover as the infection comes under control and as the antigenic load is lessened. Higgs & Wells (1972) found that patients whose candidiasis was not controlled by other measures may respond convincingly to the correction of an iron deficiency. Various tests of immunological responsiveness to candida, notably the skin reactivity, may become more positive in the process. These patients were not trcated with transfer factor, although this has provided another successful approach (see Valdimarsson et al. 1972 ). Joynson et al. (1972) have also studied the effects of iron deficiency and have come to the conclusion that its treatment may enhance the ability to mount an immune response.
The limited immune deficiencies which accompany infection have attracted a great deal of attention, and much work has been done on the pneumococcus and on many other infectious agents. Another example of a deficient response to an infective agent has been studied by Wilton et al. (1972) who noted that an impaired immune response to herpesvirus may occur when the immune response to unrelated antigens appears to be normal.
Before leaving a discussion of the depressed immune reactions which may accompany infection I should like to make one other point. Measles, infectious mononucleosis and leprosy, examples which have been quoted earlier, are often associated with the formation of autoantibodies. Antinuclear factors are common, and so are false positive Wassermann reactions. Wright & Leibowitz (1973) and Wall & Wright (1973) have shown that lepromatous leprosy is also associated, not only with clinical neuropathy and testicular disease, but with autoantibodies which react with nerve axons and with testis. Here again there is a condition associated with some degree of immune deficiency, and at the same time autoimmune reactions are a striking feature.
Immune Deficiencies in Renal Failure A reversible deficiency in immune reaction may be provoked, not only by infection, but also by malnutrition (Smythe et al. 1971 , Grace et al. 1972 , Jose & Good 1972 , by burns, and by renal failure (Nakhla & Goggin 1973) . In renal failure Boulton-Jones et al. (1973) have noted that there may be a striking depression in the primary response to keyhole limpet hemocyanin, in terms of cellular immunity as measured by lymphocyte transformation tests and also in terms of circulating antibody as judged by haemagglutination tests. Streptokinase-streptodornase skin tests were also depressed, suggesting an impaired secondary response to antigens to which the average London population has already been exposed. Patients on long-term hzemodialysis showed less striking deficiencies than those who remained in renal failure and it could sometimes be shown that when acute renal failure is reversed so are the immune deficiencies that go with it. Although Symposium on Clinical Immunology and the Physician 533 serum changes associated with nitrogen retention may have influenced these changes and toxic effects on lymphocytes may have played a part, these findings have considerable clinical significance. In the practical management of renal transplantation, this may explain some of the failures of the mixed lymphocyte culture to predict rejection, since this may only begin to occur when the patient's immune reactions have recovered from the depression which accompanies renal failure. It also helps to explain one of the reasons for the changing doses of immunosuppressive drugs which may be required at various times after a transplant. These findings provide further justification, if any is needed, for preparing patients for transplantation by longterm hemodialysis, since dialysed patients did not show the same degree of immune deficiency.
Immune Deficiency in Cancer One other large group of patients who show evidence of immune deficiency are those with cancer. The analysis of immune deficiency in this situation is difficult, especially when advanced, debilitating disease is present or when the situation is complicated by the effects of cytotoxic drugs. More clear-cut evidence of immune depression may be seen in various forms of cancer involving the lymphoreticular tissues (Table 4 ). Deficiencies in immunoglobulin production and antibody synthesis are seen in myelomatosis, and Cwynarski & Cohen (1971) have carried out a careful study in this disease. They found a significant reduction in one or other class of immunoglobulin in 82% of subjects with a monoclonal protein band. Cwynarski & Cohen then took peripheral lymphoid tissue from patients with an immunoglobulin deficiency and found that it usually failed to synthesize the corresponding immunoglobulin in vitro, but this was not because the lymphoid tissue was histologically abnormal or was synthesizing abnormal immunoglobulin.
(This was in contrast to the situation in macroglobulinemia, where the peripheral lymph nodes may themselves synthesize macroglobulins.) The peripheral spread of neoplastic cells cannot therefore explain the immunoglobulin deficiency of myeloma. This evidence from Cwynarski & Cohen strongly suggests that it is not local involvement by disease which depresses immunoglobulin production but some form of humoral regulating mechanism which no longer stimulates immunoglobulin production. The situation in Hodgkin's disease provides a sharp contrast, since here it is generally accepted that cell-mediated immunity is principally affected. Young and his colleagues at Bethesda (1973) studied 103 patients with untreated Hodgkin's disease at various stages, and they used six skin test antigens. They found that with advancing stages of the disease an increasing proportion of patients failed to respond to one or more antigens. Patients with Stage I disease had virtually normal responses, and progressive disease was accompanied not only by diminished skin reactions but also by evidence of lymphocyte abnormalities, as shown by a reduced response to phytohaemagglutinin and also, in some cases, by a reduced number of circulating lymphocytes. Perhaps this helps to explain the high incidence of herpes zoster in Hodgkin's disease which is recorded as being between 15% and 25% (Goffinet et al. 1972 , Schimpff et al. 1972 ) and is probably higher than in any other form of malignant disease.
Depression of various aspects of lymphocyte function may be noted in other forms of cancer too. Watkins (1973) studied 36 patients with nonlymphoid malignancies. In 23 of these patients she noted depressed lymphocyte response to phytohoemagglutinin, which returned to normal in all but two cases after successful surgery. Although the tests carried out were very limited, it is possible, as in infection, that immune responses may sometimes increase when the antigenic load is lessened; this is a subject which requires further study. Among the other forms of cancer which are associated with immune deficiencies, it is tempting to comment on the remarkable syndromes which are seen in patients who have had a thymoma. The deficiencies of cell-mediated immunity which are seen in this group (Jeunet & Good 1968 ) are perhaps consistent with the late effects of a destructive lesion of the thymus, and the presence of a very striking hypogammaglobulinxmia in a substantial number of cases raises again the question of a regulating factor which influences immunoglobulin production. The incidence of autoimmune reactions and the late development of other forms of cancer after the thymoma has been removed suggest other complications of a prolonged mild immune deficiency.
In summary, the long-term effects of immune deficiencies in adult life are now being studied in infection, in renal disease, in conditions such as malnutrition, burns and sarcoidosis, and in a variety of cancers affecting humoral and cell-mediated immunity in differing combinations. The clinical picture varies. Apart from an increased incidence of infections we find repeated examples of gastrointestinal syndromes, autoimmune phenomena, an increased incidence of amyloidosis and an increased tendency for cancer to develop or to spread. It is now clear that deficiencies of the immune response are common in adult life. Their full implications are still being worked out. 
DISCUSSION
The Chairman (Sir Peter Medawar) said that he would like to ask the first question, which was prompted by Professor Lessof's mention of candidiasis. He thought it would interest many of those present to have an authoritative appraisal of the likelihood of transfer factors being used for the reinstatement of immune reactivity.
Professor Lessof replied that when he mentioned that the transfer factor was not used in these particular patients, he should perhaps have mentioned the work of others, in a group which also included Dr J M Higgs and Dr R S Wells, which showed that transfer factor too could cause a dramatic remission lasting for some months. Whether this would prove to be the rather complicated answer for long-term treatment of all these patients remained to be seen.
The Chairman asked if the effect of transfer factor was confined to cell-mediated immunity, or was there any record of its having been used to reinstate tumourimmune reactivity?
Professor Lessof said that he did not know.
Dr D K Peters said that he did not think Dr H Valdimarsson was present, but he knew that he had used transfer factor in chronic mucocutaneous candidiasis with variable results. For example, one candidiasis patient who had hypoparathyroidism had shown strong cellular immunity to candida. Such patients would hardly benefit from transfer factor. Other candidiasis patients had no demonstrable cellular immunity to candida, and clearly this was a heterogeneous group of syndromes. He was sure Dr Valdimarsson would not mind his telling the meeting that they were at the present time using transfer factor in what was thought to be a humoral-mediated immunecomplex disease, namely, subacute sclerotic panencephalitis following measles infection. In one patient, at any rate, there had been a reduction in antibody titre after treatment with transfer factor. This, in response to Sir Peter Medawar's question, raised the very important and interesting possibility that humoral antibody responses could be manipulated. In the light of what had been said concerning the importance of immunodeficiency throughout medicine, this raised fascinating possibilities.
There was one other area of immunodeficiency which was becoming increasingly well recognized, namely that patients who had complement deficiencies had a relativelyshigh incidence of chronic or recurrent infection of one kind or another. This had been demonstrated in a well-studied patient in Boston, USA, who had activation of his alternate pathway and consumption of C3. Other patients with deficiencies of the early complement component Cl, Clr in particular, and C2, seemed to be present with a high incidence of immune-complex-like diseases. The interesting suggestion had been made that these patients failed to opsonize immune complexes properly, and therefore did not clear them by the reticuloendothelium system, so that they circulated in the blood for longer and were deposited in target organs such as the kidney.
Members of one family from Denver, USA, were particularly interesting in that they had hereditary angiocedema, with activation of the early classical components. Twins with this condition both had systemic lupus erythematosus.
This was a fascinating area and as complement components were measured more widely, one would expect to see more of these patients.
Dr Alejo Florin-Christensen (Middlesex Hospital, London) asked Dr Lessof why he excluded cellmediated deficiencies such as thymic dysplasias, selective immunoglobulin class deficiency and complement deficiencies, and included multiple myeloma, when antibody activities in the homogeneous proteins and normal levels of the remaining immunoglobulins were the usual finding before treatment. Professor Lessof said he showed the di George syndrome and others in the classification given in Table 1 , but he felt he should concentrate on a group rather than the whole vast subject. It was true that in a full classification of immune deficiencies these other groups were important.
He had been asked why he mentioned myeloma with low globulin among immune deficiency states. There was good evidence that these patients were more prone to infection than the population at large and he thought it was justifiable to include them. Professor Ziff, in reply to Sir Peter Medawar's question about the use of transfer factor for treating conditions in which immune complex formation or serum antibody formation might take place, said that one might envisage a condition in which there was not adequate delayed hypersensitivity to prevent a virus infection which then might take hold and in turn produce serum antibody formation and immune complexes. The initial infection might be blocked by transfer factor at the delayed hypersensitivity phase and then the immune complex disease produced by viral antibodies avoided.
Dr J F Stokes (University College Hospital, London) wondered whether Professor Lessof would enlarge upon his iron deficiency theory and quantitate it. As he understood current ideas about amyloidosis, this was one of the things which occurred with increasing age and accounted for the erratic behaviour which marked the declining years of so many people. Iron deficiency was of course also common in an ageing population. Was this important enough for the profession to get more obsessional about trying to treat the iron deficiency so often found in older people in the hope of delaying the cerebral amyloidosis which might be giving rise to one of today's main social problems?
Professor Lessof thought all were fearful of the time when cerebral atherosclerosis might provide one of the greatest social problems. However, to talk about iron deficiency in a rather speculative way, the hypothesis which made most sense to him was that chronic candidiasis was a surface infection in which recovery depended upon the repair of certain cells. When iron deficiency was corrected the exfoliation of good surface cells in the mucous membranes and elsewhere might be purely nonspecific. When talking of immune reactions, and how they went wrong, there were all kinds of nonspecific ways in which people might fail to overcome an infection and, if the skin was diseased and vulnerable, this was one of those nonspecific ways. He did not think it was more immunological than that. Dr Louis Forman (London) said that Professor Lessof had already referred to the point that he had wished to raise. If there was an anvmia sufficiently severe and prolonged the epithelium with high turnover rate and subject to trauma, such as the mucocutaneous junctions, tended to show breach of surface. Such areas were liable to infections including candida infections. This was to be seen at the angles of the mouth and in perianal skin. The restoration of anatomical integrity was important, and was sufficient to cure candida infection.
Dr Lessof referred to cancer patients who might have immunological deficiences, and who developed dermatomyositis. There was a range of skin reactions together with the muscle damage in cases of dermatomyositis. Circulating antibodies to tumour antigens and globulin deposition on the muscle had been demonstrated in these cases; therefore they were immunologically competent. Removal of the tumour could relieve the skin and muscle signs within days.
Professor Lessof agreed that there were many degrees of immune deficiency. Some of those to which he had referred were of minor degree and might not be of great concern. The association of dermatomyositis with well-characterized, quite severe immune deficiencies was one situation where the suggestion was that if there was a fairly gross immune deficiency the patient might be more liable to this kind of reaction. He agreed that if there were no reaction at all dermatomyositis could not develop.
As for candida, he had intended that illustration to show one point of interest, namely, that when a chronic infection of this type was corrected, even if it was corrected by a totally non-immunological mechanism, one of the results was that the antigenic load diminished. Perhaps this explained why skin reactions and similar responses, which were depressed during the acute phases of the disease, might recover and why the immumological reactions were then more in evidence. Dr A R Hayward (Institute of Child Health, London) referred again to the treatment of candidiasis by iron. Some of Dr Higg's patients had had very low serum iron without being very anzmic, so a relatively normal hemoglobin did not preclude a response to iron. Also, iron was a simpler and less expensive form of treatment than transfer factor. The mechanism of response to iron was unclear: one possibility was that low concentrations of iron in the tissues promoted the growth of candida organisms in a hyphal, invasive, form. Other work, however, suggested that iron could also have direct effects on the reactivity of lymphocytes (Fletcher et al. 1974, submitted for publication).
Professor Lessof replied that he realized much more could be said on this question and he was grateful to Dr Hayward, who had been associated with this work, for his comments. He agreed that iron might well have immunological effects. Dr B Mornington ( Wellcome Foundation, London) said Professor Lessof stated that immune deficiency caused autoimmune diseases such as systemic lupus; this seemed rather paradoxical, particularly in view of the value of immunosuppressive therapy in systemic lupus. Professor Lessof replied that he did not say immune deficiency caused autoimmune reactions although, in immune deficiency states, there were many examples of situations where autoimmune reactions became more common. It had been speculated that these reactions might be a reflexion of a failure to eliminate antigen and an indication of immune deficiency. This was the challenging concept which he wished to repeat. He thought, in practice, that until there was a better approach the clinical empirical use of drugs for systemic lupus would have to continue as before. If attention was paid to these associations of immune deficiency with increased evidence of autoimmunity, one merely became more conscious of the failings of present therapeutic philosophy. An unidentified speaker said that he was stimulated by Professor Lessof's comments on iron deficiency and how this could not always be equated with hemoglobin. He was at present looking at cytochrome mitochondria and he immediately thought ofiron deficiency being involved in cytochrome synthesis. One of the aspects of these general-features of deficiency perhaps might be looked at with respect to energy requirement. It was known that in all these reactions there was a quite stringent requirement for ATP for example, and one immediately thought of mitochondria. Possibly this was a common factor, and perhaps cytochrome synthesis and the proteins involved in the respiratory chain were behind it. However, he did not know of any examples which could be tied down to a deficiency in cytochromes or in respiratory activity, but he did not know that there were examples in other organisms where deficiency, for example in cytochrome C, could lead to susceptibility to antibiotics and that aplastic anxmias, for instance, might result, which could be related back to a deficiency in cytochrome C. Dr W J Irvine wished to comment on the paradox between immunodeficiency and autoimmune disease. One of the attractive hypotheses was that the T-cells might have a physiologically controlling influence on what the B-cells making the antibodies might do, so that if there was an immunodeficiency of T-cells there might be an over-activity of the other cellular components of the immune system. Hence if the Tcells in an experimental animal were removed by thymectomy and there was subsequent sublethal irradiation, not only antinuclear factors but experimental thyroiditis would be produced, or, at least, thyroiditis would spontaneously appear. This at least gave an idea of how an immune deficiency might link up with an autoimmune disease. Professor Ziff said that there was some evidence for the point of view that the T-cell produced an immuno-depressive substance which kept the B-cell from acting. Talal had recently injected NZB mice with BCG. In so doing he had been able to eliminate any nuclear response in these animals. Professor Coombs wished to mention one more factor in the discussion of immunodeficiency in autoantibody formation. One of the main causes associated with autoantibody formation was infection. With immunodeficiency there was more infection and therefore more likelihood of initiating an autoantibody formation. An unidentified speaker said he had intended to make that point and add one comment. In the so-called autoimmune diseases which had been studied carefully in man and in experimental animals, in the majority of instances where the primary causes of the immunological event was known, this turned out to be an infection. For example, nearly all types of spontaneous nephritis in animal experiments could be shown to be due to an infection. In man, in the majority of instances in which the cause was known it was also due to an infection, although, of course, the cause was usually not known. Professor Lessof: I would agree heartily with that.
B-and T-Lymphocytes in Rheumatoid
Synovitis and the Effect of Cyclophosphamide by Professor M Ziff MD, E R Hurd MD and P Stastny MD (Department ofInternal Medicine, Rheumatic Diseases Unit, University ofTexas Southwestern Medical School, Dallas, Texas, USA)
The rheumatoid synovial membrane has perivascular mononuclear infiltrates in the sublining layer. When examined in the electron microscope, these infiltrates show a unique pattern of infiltration (Kobayashi et al. 1973) . Some consist almost entirely of small lymphocytes ( Fig I) and others mainly of plasma cells (Fig 2) . Transitional areas made up of both lymphocytes and plasma cells cells are also present. Both the lymphocyte-rich and the plasma-cell-rich areas contain blastic cells. Some of these have aggregated polyribosomes and nucleoli but no endoplasmic reticulum and have the appearance of lymphoblasts. Others contain endoplasmic reticulum and have the appearance of plasmablasts. It is of interest that the transitional areas are particularly rich in blast cells (Ishikawa & Ziff, unpublished data): the transitional areas contained 27.1 % blast cells in comparison with approximately 5 % of these cells in the other areas.
